CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? - Authors' reply. Fennell DA, Griffiths G, Ottensmeier C, Hanna GG, et al. Lancet Oncol 2022;23:e14-e15.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fennell DA, Griffiths G, Ottensmeier C, Hanna GG, et al. CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? - Authors' reply. Lancet Oncol 2022;23:e14-e15.
PMID: 34973224